CHARITY HOLTSCLAW: Open Payments
NPI 1770247074 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 27 payments from 12 companies in 2025. Trend: 2023 $21 · 2024 $410 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $353 |
| Novo Nordisk Inc | 5 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Astellas Pharma US Inc | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Exact Sciences Corporation | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Cranial Technologies, Inc | 1 | $16 |
Products named: AIRSUPRA, BREZTRI, CAPLYTA, Veozah, Wegovy, REXULTI, Auvelity, Ozempic.
Industry payments across IN — which companies pay providers there.
